Chronic kidney disease (CKD) is increasingly recognized as a major global health issue, and disparities in healthcare access ...

Denosumab treatment for osteoporosis appears more hazardous in postmenopausal women with advanced chronic kidney disease (CKD).

Nearly 300,000 bottles of the drug, named Cinacalcet, were recalled and given a Class II recall risk level by the FDA.

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says.

This syndrome plays a significant role in elevating the risk of developing cardiovascular diseases, which encompass serious ...

People with chronic kidney disease and type 2 diabetes may face heart disease up to 28 years earlier than others.

New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...

New discoveries in atherosclerosis pathways have shed light on the active mechanisms in other diseases such as chronic kidney disease (CKD) and HIV, paving the way for furture therapeutics.

Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.